Brandywine Global Investment Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $216M | Sell |
2,723,074
-414,402
| -13% | -$32.7M | 1.45% | 10 |
|
|
2025
Q3 | $237M | Sell |
3,137,476
-12,839
| -0.4% | -$880K | 1.62% | 8 |
|
|
2025
Q2 | $217M | Sell |
3,150,315
-271,204
| -8% | -$17.8M | 1.53% | 9 |
|
|
2025
Q1 | $232M | Buy |
3,421,519
+572,533
| +20% | +$34.3M | 1.67% | 8 |
|
|
2024
Q4 | $128M | Buy |
2,848,986
+650,832
| +30% | +$36.5M | 0.93% | 22 |
|
|
2024
Q3 | $148M | Buy |
2,198,154
+243,266
| +12% | +$14.2M | 0.99% | 18 |
|
|
2024
Q2 | $115M | Sell |
1,954,888
-361,763
| -16% | -$22.6M | 0.86% | 22 |
|
|
2024
Q1 | $185M | Buy |
2,316,651
+232,505
| +11% | +$17.8M | 1.33% | 8 |
|
|
2023
Q4 | $165M | Buy |
2,084,146
+553,779
| +36% | +$39.4M | 1.32% | 7 |
|
|
2023
Q3 | $107M | Buy |
1,530,367
+39,960
| +3% | +$2.83M | 0.94% | 15 |
|
|
2023
Q2 | $103M | Sell |
1,490,407
-473,196
| -24% | -$33.7M | 0.86% | 22 |
|
|
2023
Q1 | $146M | Buy |
1,963,603
+146,163
| +8% | +$12.3M | 1.18% | 13 |
|
|
2022
Q4 | $169M | Buy |
1,817,440
+105,655
| +6% | +$10.2M | 1.32% | 10 |
|
|
2022
Q3 | $163M | Buy |
1,711,785
+23,215
| +1% | +$2.3M | 1.52% | 5 |
|
|
2022
Q2 | $156M | Sell |
1,688,570
-78,675
| -4% | -$7.68M | 1.36% | 9 |
|
|
2022
Q1 | $179M | Sell |
1,767,245
-68,414
| -4% | -$7.19M | 1.31% | 7 |
|
|
2021
Q4 | $189M | Sell |
1,835,659
-115
| -0% | -$10.6K | 1.35% | 8 |
|
|
2021
Q3 | $156M | Sell |
1,835,774
-152,653
| -8% | -$12.8M | 1.18% | 11 |
|
|
2021
Q2 | $166M | Buy |
1,988,427
+1,059,360
| +114% | +$86.8M | 1.23% | 13 |
|
|
2021
Q1 | $69.9M | Buy |
929,067
+86,075
| +10% | +$6.27M | 0.53% | 35 |
|
|
2020
Q4 | $57.6M | Buy |
842,992
+27,624
| +3% | +$1.8M | 0.48% | 50 |
|
|
2020
Q3 | $47.6M | Buy |
815,368
+8,676
| +1% | +$540K | 0.47% | 51 |
|
|
2020
Q2 | $52.4M | Sell |
806,692
-6,169
| -0.8% | -$388K | 0.53% | 39 |
|
|
2020
Q1 | $48.2M | Sell |
812,861
-535,467
| -40% | -$35.7M | 0.58% | 35 |
|
|
2019
Q4 | $100M | Sell |
1,348,328
-64,550
| -5% | -$4.53M | 0.7% | 33 |
|
|
2019
Q3 | $89.1M | Sell |
1,412,878
-48,969
| -3% | -$2.9M | 0.65% | 35 |
|
|
2019
Q2 | $79.7M | Sell |
1,461,847
-12,805
| -0.9% | -$690K | 0.55% | 41 |
|
|
2019
Q1 | $79.5M | Buy |
1,474,652
+480,511
| +48% | +$29.7M | 0.55% | 47 |
|
|
2018
Q4 | $65.1M | Sell |
994,141
-161,401
| -14% | -$12M | 0.48% | 53 |
|
|
2018
Q3 | $91M | Sell |
1,155,542
-21,785
| -2% | -$1.56M | 0.57% | 45 |
|
|
2018
Q2 | $75.8M | Sell |
1,177,327
-59,637
| -5% | -$3.93M | 0.48% | 50 |
|
|
2018
Q1 | $77M | Sell |
1,236,964
-566,542
| -31% | -$40.6M | 0.48% | 49 |
|
|
2017
Q4 | $131M | Buy |
1,803,506
+233,099
| +15% | +$16.9M | 0.78% | 29 |
|
|
2017
Q3 | $128M | Buy |
1,570,407
+582,652
| +59% | +$46.1M | 0.81% | 25 |
|
|
2017
Q2 | $79.5M | Buy |
+987,755
| New | +$78M | 0.51% | 47 |
|
|
2016
Q4 | – | Sell |
-948,830
| Closed | -$84.4M | – | 948 |
|
|
2016
Q3 | $84.4M | Buy |
+948,830
| New | +$89.6M | 0.56% | 48 |
|
|
2016
Q1 | – | Sell |
-629
| Closed | -$62K | – | 982 |
|
|
2015
Q4 | $62K | Hold |
629
| – | – | ﹤0.01% | 807 |
|
|
2015
Q3 | $61K | Sell |
629
-139,302
| -100% | -$14.6M | ﹤0.01% | 834 |
|
|
2015
Q2 | $14.7M | Sell |
139,931
-128
| -0.1% | -$13.1K | 0.09% | 191 |
|
|
2015
Q1 | $14.5M | Buy |
140,059
+489
| +0.4% | +$49.5K | 0.09% | 194 |
|
|
2014
Q4 | $13.4M | Sell |
139,570
-716,044
| -84% | -$63.1M | 0.09% | 201 |
|
|
2014
Q3 | $68.1M | Buy |
855,614
+160,890
| +23% | +$12.7M | 0.5% | 50 |
|
|
2014
Q2 | $52.4M | Buy |
694,724
+100,393
| +17% | +$7.59M | 0.41% | 54 |
|
|
2014
Q1 | $44.5M | Buy |
594,331
+9,161
| +2% | +$647K | 0.39% | 54 |
|
|
2013
Q4 | $41.9M | Buy |
585,170
+6,760
| +1% | +$434K | 0.38% | 55 |
|
|
2013
Q3 | $32.8M | Buy |
578,410
+59,830
| +12% | +$3.57M | 0.33% | 68 |
|
|
2013
Q2 | $29.7M | Buy |
+518,580
| New | +$30M | 0.3% | 71 |
|
Other funds holding CVS
Brandywine Global Investment Management's CVS Position: Q4 2025 in Review
Brandywine Global Investment Management reduced its CVS Health (CVS) stake by 13% in Q4 2025, selling an estimated $32.7M and leaving 2,723,074 shares worth $216M. The position accounts for 1.45% of the portfolio, ranked #10.
Brandywine Global Investment Management first reported a position in CVS in Q2 2013 and has held it in 47 quarters since. The position peaked at $237M in Q3 2025. 1,945 funds tracked by Wall St. Rank hold CVS as of Q4 2025.
- Brandywine Global Investment Management held 2,723,074 shares of CVS Health worth $216M as of Q4 2025.
- Brandywine Global Investment Management sold 414,402 CVS Health shares in Q4 2025, an estimated $32.7M.
- CVS Health made up 1.45% of Brandywine Global Investment Management's portfolio in Q4 2025, its #10 holding.
- Brandywine Global Investment Management first reported a position in CVS Health in Q2 2013 and has held it in 47 quarters since.
- Brandywine Global Investment Management's CVS Health position peaked at $237M in Q3 2025.
- 1,945 funds tracked by Wall St. Rank held CVS Health as of Q4 2025.
Based on Brandywine Global Investment Management's 13F filing for Q4 2025, filed 11 Feb 2026.